New Multiplex Real-time PCR for Genital Ulcer Disease

(i) To compare a new diagnostic PCR with established diagnostic procedures for T. pallidum (serology, dark field microscopy), H. ducreyi (cultivation), HSV types 1 and 2 (cultivation, PCR).

(ii) To assess the frequency of infections with T. pallidum, H. ducreyi and HSV types 1 and 2 in patients with genital, anal and oropharyngeal ulcers by a new PCR.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Genital Ulcer Disease (GUD)

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich, Division of Dermatology

Zurich, Canton of Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with genital, anal or oropharyngeal ulcers
Age minimum of 18 years.
Informed consent must be obtained from each patient/control patient in written form prior to any study procedure.

Exclusion criteria

Antibiotic therapy within 2 weeks before the visit

Treatment and study plan

Diagnostic swab

Procedure

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

A Prospective, Open Labeled, Multicenter, Diagnostic Study on the Detection of T. Pallidum, H. Ducreyi and HSV Type 1 and 2 From Genital, Anal and Oropharyngeal Ulcers With a New Multiplex Real-time Polymerase Chain Reaction

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Sep 19, 2012
Registry last updated: Jul 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.